LA
CVS icon

LexAurum Advisors’s CVS Health CVS Stock Holding History

LexAurum Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
4,215
-318
-7% -$28.4K 0.05% 271
2026
Q1 		$326K Buy
+4,533
New +$349K 0.04% 310
2025
Q3 		$381K Sell
5,049
-590
-10% -$40.4K 0.05% 251
2025
Q2 		$389K Sell
5,639
-155
-3% -$10.2K 0.06% 228
2025
Q1 		$393K Sell
5,794
-133
-2% -$7.96K 0.08% 225
2024
Q4 		$266K Buy
5,927
+83
+1% +$4.66K 0.05% 280
2024
Q3 		$367K Buy
5,844
+10
+0.2% +$583 0.08% 210
2024
Q2 		$345K Buy
5,834
+31
+0.5% +$1.94K 0.08% 206
2024
Q1 		$463K Sell
5,803
-983
-14% -$75.1K 0.12% 160
2023
Q4 		$536K Buy
6,786
+599
+10% +$42.6K 0.14% 145
2023
Q3 		$432K Sell
6,187
-5
-0.1% -$354 0.13% 158
2023
Q2 		$428K Buy
6,192
+1,233
+25% +$87.7K 0.13% 149
2023
Q1 		$368K Sell
4,959
-94
-2% -$7.88K 0.12% 156
2022
Q4 		$471K Buy
5,053
+104
+2% +$10K 0.17% 124
2022
Q3 		$472K Buy
4,949
+159
+3% +$15.7K 0.18% 120
2022
Q2 		$444K Buy
4,790
+4
+0.1% +$390 0.17% 128
2022
Q1 		$484K Sell
4,786
-96
-2% -$10.1K 0.16% 128
2021
Q4 		$504K Buy
4,882
+4
+0.1% +$370 0.16% 134
2021
Q3 		$414K Buy
4,878
+290
+6% +$24.3K 0.12% 185
2021
Q2 		$383K Buy
4,588
+605
+15% +$49.5K 0.11% 195
2021
Q1 		$300K Sell
3,983
-220
-5% -$16K 0.1% 200
2020
Q4 		$287K Sell
4,203
-193
-4% -$12.6K 0.1% 190
2020
Q3 		$257K Sell
4,396
-605
-12% -$37.6K 0.11% 187
2020
Q2 		$325K Buy
5,001
+131
+3% +$8.25K 0.18% 128
2020
Q1 		$289K Buy
4,870
+158
+3% +$10.5K 0.2% 113
2019
Q4 		$350K Buy
4,712
+1,212
+35% +$85.1K 0.17% 134
2019
Q3 		$221K Buy
+3,500
New +$207K 0.13% 168

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

LexAurum Advisors's CVS Position: Q2 2026 in Review

LexAurum Advisors reduced its CVS Health (CVS) stake by 7% in Q2 2026, selling an estimated $28.4K and leaving 4,215 shares worth $436K. The position accounts for 0.05% of the portfolio, ranked #271.

LexAurum Advisors first reported a position in CVS in Q3 2019 and has held it in 27 quarters since. The position peaked at $536K in Q4 2023. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • LexAurum Advisors held 4,215 shares of CVS Health worth $436K as of Q2 2026.
  • LexAurum Advisors sold 318 CVS Health shares in Q2 2026, an estimated $28.4K.
  • CVS Health made up 0.05% of LexAurum Advisors's portfolio in Q2 2026, its #271 holding.
  • LexAurum Advisors first reported a position in CVS Health in Q3 2019 and has held it in 27 quarters since.
  • LexAurum Advisors's CVS Health position peaked at $536K in Q4 2023.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.